Cargando…
Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
Pharmacokinetic/pharmacodynamic (PK/PD) integration models are used to investigate the antimicrobial activity characteristics of drugs targeting pathogenic bacteria through comprehensive analysis of the interactions between PK and PD parameters. PK/PD models have been widely applied in the developme...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989418/ https://www.ncbi.nlm.nih.gov/pubmed/35400105 http://dx.doi.org/10.3389/fvets.2022.860472 |
_version_ | 1784683168150847488 |
---|---|
author | Zhang, Longfei Xie, Hongbing Wang, Yongqiang Wang, Hongjuan Hu, Jianhe Zhang, Gaiping |
author_facet | Zhang, Longfei Xie, Hongbing Wang, Yongqiang Wang, Hongjuan Hu, Jianhe Zhang, Gaiping |
author_sort | Zhang, Longfei |
collection | PubMed |
description | Pharmacokinetic/pharmacodynamic (PK/PD) integration models are used to investigate the antimicrobial activity characteristics of drugs targeting pathogenic bacteria through comprehensive analysis of the interactions between PK and PD parameters. PK/PD models have been widely applied in the development of new drugs, optimization of the dosage regimen, and prevention and treatment of drug-resistant bacteria. In PK/PD analysis, minimal inhibitory concentration (MIC) is the most commonly applied PD parameter. However, accurately determining MIC is challenging and this can influence the therapeutic effect. Therefore, it is necessary to optimize PD indices to generate more rational results. Researchers have attempted to optimize PD parameters using mutant prevention concentration (MPC)-based PK/PD models, multiple PD parameter-based PK/PD models, kill rate-based PK/PD models, and others. In this review, we discuss progress on PD parameters for PK/PD models to provide a valuable reference for drug development, determining the dosage regimen, and preventing drug-resistant mutations. |
format | Online Article Text |
id | pubmed-8989418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89894182022-04-08 Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models Zhang, Longfei Xie, Hongbing Wang, Yongqiang Wang, Hongjuan Hu, Jianhe Zhang, Gaiping Front Vet Sci Veterinary Science Pharmacokinetic/pharmacodynamic (PK/PD) integration models are used to investigate the antimicrobial activity characteristics of drugs targeting pathogenic bacteria through comprehensive analysis of the interactions between PK and PD parameters. PK/PD models have been widely applied in the development of new drugs, optimization of the dosage regimen, and prevention and treatment of drug-resistant bacteria. In PK/PD analysis, minimal inhibitory concentration (MIC) is the most commonly applied PD parameter. However, accurately determining MIC is challenging and this can influence the therapeutic effect. Therefore, it is necessary to optimize PD indices to generate more rational results. Researchers have attempted to optimize PD parameters using mutant prevention concentration (MPC)-based PK/PD models, multiple PD parameter-based PK/PD models, kill rate-based PK/PD models, and others. In this review, we discuss progress on PD parameters for PK/PD models to provide a valuable reference for drug development, determining the dosage regimen, and preventing drug-resistant mutations. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8989418/ /pubmed/35400105 http://dx.doi.org/10.3389/fvets.2022.860472 Text en Copyright © 2022 Zhang, Xie, Wang, Wang, Hu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Zhang, Longfei Xie, Hongbing Wang, Yongqiang Wang, Hongjuan Hu, Jianhe Zhang, Gaiping Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title | Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title_full | Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title_fullStr | Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title_full_unstemmed | Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title_short | Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models |
title_sort | pharmacodynamic parameters of pharmacokinetic/pharmacodynamic (pk/pd) integration models |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989418/ https://www.ncbi.nlm.nih.gov/pubmed/35400105 http://dx.doi.org/10.3389/fvets.2022.860472 |
work_keys_str_mv | AT zhanglongfei pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels AT xiehongbing pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels AT wangyongqiang pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels AT wanghongjuan pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels AT hujianhe pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels AT zhanggaiping pharmacodynamicparametersofpharmacokineticpharmacodynamicpkpdintegrationmodels |